Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
Clinical trial NCT04655118 · UNKNOWN
Trial details
- NCT number
- NCT04655118
- Sponsor
- Telios Pharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-22
- Primary completion
- 2025-06-30
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.